Skip to main content
Cyber Week Sale - Get 40% off Vantage
Published loading...Updated

Alzheimer's Disease Blood Biomarkers Increase up to 95% Faster in Obese Individuals

Obesity accelerates Alzheimer's blood biomarker increases by up to 95%, suggesting faster disease progression, based on five-year data from 407 participants in the Alzheimer's Disease Neuroimaging Initiative.

  • On Dec. 2, 2025, researchers presented at the Radiological Society of North America that blood-based biomarkers rose up to 95% faster in people with obesity than in non-obese individuals.
  • Researchers analyzed five-year ADNI data from 407 participants, testing plasma pTau217, neurofilament light chain and GFAP with six leading commercial tests, validating BBMs against amyloid PET and using statistical models assessing BMI-time-BBM interactions.
  • At baseline, body mass index correlated with lower blood biomarkers and reduced whole‑brain amyloid burden, but obesity led to a 24% faster plasma neurofilament light chain increase and 3.7% faster amyloid accumulation.
  • Implications for clinical practice include obesity being a potential risk factor, with Dr. Raji noting `this is the first time we've shown the relationship between obesity and Alzheimer's disease as measured by blood biomarker tests.`
  • Caution is advised because results remain preliminary until peer‑reviewed publication; Raji expects longitudinal blood biomarkers and brain imaging will monitor patients on anti‑amyloid drugs, while trials could test obesity/weight‑loss drugs.
Insights by Ground AI

Bias Distribution

  • 50% of the sources are Center
50% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

PR Newswire broke the news in United States on Tuesday, December 2, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal